Top

Cancer Cell International

Published in:

Open Access 01-12-2020 | Correction

Correction to: Relationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro study

Published in: Cancer Cell International | Issue 1/2020

Title: Correction to: Relationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro study
Publication date: 01-12-2020
Published in: Cancer Cell International / Issue 1/2020
Electronic ISSN: 1475-2867
DOI: https://doi.org/10.1186/s12935-020-1138-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2020

The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer

GPX8 is transcriptionally regulated by FOXC1 and promotes the growth of gastric cancer cells through activating the Wnt signaling pathway

Construction of a metastasis-associated ceRNA network reveals a prognostic signature in lung cancer

Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer

Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma

Comprehensive analysis of key genes associated with ceRNA networks in nasopharyngeal carcinoma based on bioinformatics analysis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer